Compounds > pyrazines
Page last updated: 2024-08-21

pyrazines and moxifloxacin

pyrazines has been researched along with moxifloxacin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Bergman, AJ; Bloomfield, DM; Ghosh, K; Gottesdiener, KM; Gutierrez, MJ; Herman, GA; Hickey, L; Hreniuk, D; Krishna, R; Miller, J; Stoltz, R; Wagner, JA1
Bruderer, S; Darpo, B; Dingemanse, J; Hoch, M; Kaufmann, P; Remenova, T; Stoltz, R; Zhou, M1
Ahmed, GF; Dota, CD; Ghiorghiu, D; Goldwater, R; Li, Y; Mellemgaard, A; Sahota, T; Verheijen, RB; Vik, T; Walker, S; Yan, W1

Trials

3 trial(s) available for pyrazines and moxifloxacin

ArticleYear
A thorough QTc study to assess the effect of sitagliptin, a DPP4 inhibitor, on ventricular repolarization in healthy subjects.
    Journal of clinical pharmacology, 2009, Volume: 49, Issue:8

    Topics: Adolescent; Adult; Aza Compounds; Cross-Over Studies; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Humans; Male; Middle Aged; Models, Biological; Moxifloxacin; Pyrazines; Quinolines; Sensitivity and Specificity; Sitagliptin Phosphate; Time Factors; Triazoles; Young Adult

2009
A thorough QT study in the context of an uptitration regimen with selexipag, a selective oral prostacyclin receptor agonist.
    Drug design, development and therapy, 2015, Volume: 9

    Topics: Acetamides; Administration, Oral; Adolescent; Adult; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Placebos; Pyrazines; Receptors, Epoprostenol; Receptors, Prostaglandin; Young Adult

2015
A Randomized, Double-Blind, Placebo- and Positive-Controlled, Three-Way Crossover Study in Healthy Participants to Investigate the Effect of Savolitinib on the QTc Interval.
    Clinical pharmacology in drug development, 2021, Volume: 10, Issue:5

    Topics: Adult; Cross-Over Studies; Double-Blind Method; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Protein Kinase Inhibitors; Pyrazines; Triazines

2021